Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 84
Selected: 0
NCT IDTitle
NCT04697069A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash
NCT07065773Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
NCT04140695Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)
NCT02560103An Observational Study to Investigate the Effects of Rapid Transmeridian Travel
NCT07221578Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder
NCT07179055An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
NCT02231008Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS
NCT07090161Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
NCT05361707Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
NCT04712734A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia
NCT01430754Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
NCT05922995The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)
NCT02776215Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
NCT04819776Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
NCT04622345Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies
NCT05572281Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers
NCT06830044Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
NCT00467441VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
NCT04697056A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis
NCT02970968Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
NCT00548340VEC-162 Study in Adult Patients With Primary Insomnia
NCT01348100Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients
NCT01291511Relapse Prevention Study in Patients With Schizophrenia
NCT02180451Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)
NCT01428661Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
NCT02004041Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis
NCT04353401WGS Analysis of COVID-19 Positive Patients
NCT06961968Randomized Withdrawal Study in Patients With Schizophrenia
NCT07223632Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient
NCT06323655Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects
NCT01477619Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects
NCT06836557Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
NCT00291187VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia
NCT01540500Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine
NCT02621385Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects
NCT02651714Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
NCT04028492Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
NCT03619902A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis
NCT06953869Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
NCT04474990Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis
NCT04652882Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
NCT04800237Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety
NCT06803290Food Effect Study of VHX-896 in Healthy Volunteers
NCT03291041A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
NCT06296966A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
NCT01195558Patient Registry of Blind Subjects With Sleep-related Problems
NCT05344365A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
NCT01495169Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
NCT01919944Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P
NCT06494397Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions